Evidence-based dentistry

Chlorhexidine oral care may reduce the risk of pneumonia in ventilated patients

Updated

Abstract

Oral hygiene care, including chlorhexidine mouthwash or gel, reduces the risk of ventilator-associated pneumonia (VAP) from 25% to about 19% in critically ill patients.

  • Chlorhexidine mouthrinse or gel is associated with a reduced risk of VAP compared to placebo or usual care.
  • There is no evidence of a difference in mortality rates or duration of mechanical ventilation between chlorhexidine and placebo/usual care.
  • Toothbrushing's effect on VAP risk and mortality is uncertain, with low to very low quality evidence.
  • Weak evidence suggests that povidone iodine mouthrinse may be more effective than saline/placebo in reducing VAP.
  • Insufficient evidence exists regarding the effectiveness of powered toothbrushes or other oral care solutions in reducing VAP.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free